MERTK and leukemia: Here, we found that MRX2843 treatment similarly decreased STAT6 phosphorylation in leukemia-exposed macrophages, providing a plausible mechanism by which MerTK inhibition leads to macrophage repolarization from cancer-promoting toward a classically activated phenotype.